Th17 Pathway Plasticity in the Pathogenesis of Inflammatory Bowel Disease

炎症性肠病发病机制中的 Th17 通路可塑性

基本信息

  • 批准号:
    9099835
  • 负责人:
  • 金额:
    $ 33.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Th17 Pathway Plasticity in the Pathogenesis of Inflammatory Bowel Disease. The Th17 subset has been implicated in a number of immune-mediated diseases, including IBD. Despite the acknowledged importance of the Th17/IL-23 axis in intestinal inflammation, questions remain regarding stability of the Th17 lineage and the role of IFN- in colitis pathogenesis. In human and mouse colitis, T cells that express either IL-17A or IFN-, or both are found in inflamed intestinal tissues. In published studies we have found using novel cytokine reporter mice that Th17 cells show late developmental plasticity, such that under the influence of IL-23, Th17 cells can deviate to IFN-+ cells (`Th1-like' cells) in a mannr that is dependent on the transcription factors Stat4 and T-bet. Our new preliminary data show that Th17 cells deficient in Stat4 or T-bet are impaired in their transition to IFN-+ cells in vvo, and their colitogenic potential is markedly reduced. Similarly, Th17 cells that are deficient in IFN- do not induce colitis. We hypothesize that IL-17A and IFN- producing cells arise from common Th17 precursors under the influence of IL-23 and have distinct roles in IBD pathogenesis: IFN-+ Th1-like cells are required for disease development whereas mature Th17 cells that express only IL-17A are protective. In this proposal we will explore how late diversity n Th17 differentiation impacts IBD development by using recently created IL-17A reporter mice to (i) study the contribution of Th17-derived IL-17A+ and IFN-+ cells to the development of colitis and (ii) define mechanisms by which Th1-like cells derived from the Th17 pathway drive intestinal inflammation.
 描述(由申请人提供):炎症性肠病发病机制中的Th 17通路可塑性。Th 17亚群与许多免疫介导的疾病有关,包括IBD。尽管Th 17/IL-23轴在肠道炎症中的重要性已被公认,但关于Th 17谱系的稳定性和IFN-γ在结肠炎发病机制中的作用仍存在问题。在人类和小鼠结肠炎中,在发炎的肠组织中发现表达IL-17 A或IFN-γ或两者的T细胞。在已发表的研究中,我们发现使用新的细胞因子报告小鼠,Th 17细胞显示晚期发育可塑性,使得在IL-23的影响下,Th 17细胞可以依赖于转录因子Stat 4和T-bet的方式偏离为IFN-γ +细胞(“Th 1样”细胞)。我们的新的初步数据表明,缺乏Stat 4或T-bet的Th 17细胞在体外向IFN-γ +细胞的转化中受损,并且它们的大肠杆菌生成潜力显著降低。类似地,缺乏IFN-γ的Th 17细胞不诱导结肠炎。我们假设IL-17 A和IFN-γ产生细胞在IL-23的影响下由共同的Th 17前体产生,并且在IBD发病机制中具有不同的作用:IFN-γ + Th 1样细胞是疾病发展所需的,而仅表达IL-17 A的成熟Th 17细胞是保护性的。在这项提案中,我们将探索晚期Th 17分化的多样性如何影响IBD的发展,通过使用最近创建的IL-17 A报告小鼠来(i)研究Th 17衍生的IL-17 A+和IFN-γ +细胞对结肠炎发展的贡献,以及(ii)定义Th 17途径衍生的Th 1样细胞驱动肠道炎症的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Casey T Weaver其他文献

Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model1
  • DOI:
    10.1186/1471-2172-10-44
  • 发表时间:
    2009-08-03
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Joseph H Chewning;Kari J Dugger;Tandra R Chaudhuri;Kurt R Zinn;Casey T Weaver
  • 通讯作者:
    Casey T Weaver

Casey T Weaver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Casey T Weaver', 18)}}的其他基金

Coordination of Innate and Adaptive Immunity in Intestinal Barrier Defense
肠道屏障防御中先天性免疫和适应性免疫的协调
  • 批准号:
    10580812
  • 财政年份:
    2022
  • 资助金额:
    $ 33.08万
  • 项目类别:
Coordination of Innate and Adaptive Immunity in Intestinal Barrier Defense
肠道屏障防御中先天性免疫和适应性免疫的协调
  • 批准号:
    10467141
  • 财政年份:
    2022
  • 资助金额:
    $ 33.08万
  • 项目类别:
Specialization of Innate and Adaptive Immune Cells in Intestinal Barrier Function
先天性和适应性免疫细胞在肠道屏障功能中的专业化
  • 批准号:
    10113590
  • 财政年份:
    2017
  • 资助金额:
    $ 33.08万
  • 项目类别:
Th17 Pathway Plasticity in the Pathogenesis of Inflammatory Bowel Disease
炎症性肠病发病机制中的 Th17 通路可塑性
  • 批准号:
    9306839
  • 财政年份:
    2015
  • 资助金额:
    $ 33.08万
  • 项目类别:
Molecular Regulation of MS Susceptibility Genes
MS 易感基因的分子调控
  • 批准号:
    8676653
  • 财政年份:
    2013
  • 资助金额:
    $ 33.08万
  • 项目类别:
Molecular Regulation of MS Susceptibility Genes
MS 易感基因的分子调控
  • 批准号:
    8560515
  • 财政年份:
    2013
  • 资助金额:
    $ 33.08万
  • 项目类别:
Molecular Regulation of MS Susceptibility Genes
MS 易感基因的分子调控
  • 批准号:
    9099643
  • 财政年份:
    2013
  • 资助金额:
    $ 33.08万
  • 项目类别:
Factors Controlling Effector T Cell Maintenance in the Pathogenesis of Colitis
结肠炎发病机制中效应 T 细胞维持的控制因素
  • 批准号:
    8895306
  • 财政年份:
    2011
  • 资助金额:
    $ 33.08万
  • 项目类别:
Factors Controlling Effector T Cell Maintenance in the Pathogenesis of Colitis
结肠炎发病机制中效应 T 细胞维持的控制因素
  • 批准号:
    8334504
  • 财政年份:
    2011
  • 资助金额:
    $ 33.08万
  • 项目类别:
Factors Controlling Effector T Cell Maintenance in the Pathogenesis of Colitis
结肠炎发病机制中效应 T 细胞维持的控制因素
  • 批准号:
    8703090
  • 财政年份:
    2011
  • 资助金额:
    $ 33.08万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了